Images Powered by Shutterstock
‘Encouraging’ results with transurethral resection, systemic therapy for bladder cancer

‘Encouraging’ results with transurethral resection, systemic therapy for bladder cancer

Galsky reports research funding to his institution from or consultant/advisory roles with Aileron Therapeutics, Astellas, AstraZeneca, Bristol Myers Squibb, Dendreon, Eli Lilly,...

Bladder cancer - Symptoms and causes

Bladder cancer - Symptoms and causes

Male urinary system Male urinary system Your urinary system — which includes your kidneys, ureters, bladder and urethra — removes waste from your body through urine. Your...

Immunotherapy Drug Lowers Risk of Bladder Cancer Returning after Surgery

Immunotherapy Drug Lowers Risk of Bladder Cancer Returning after Surgery

People whose bladder cancer has spread into the muscle wall may soon have a new treatment option after surgery that will help keep the cancer from returning. A large,...

Can You Keep Your Bladder After Bladder Cancer Strikes?

Can You Keep Your Bladder After Bladder Cancer Strikes?

MONDAY, June 7, 2021 (HealthDay News) -- After being diagnosed with bladder cancer, some patients face an almost impossible decision -- have their bladder removed or take a risk...

Deep learning-based classification of blue light cystoscopy imaging during transurethral resection of bladder tumors

Deep learning-based classification of blue light cystoscopy imaging during transurethral resection of bladder tumors

Deep learning-based classification of blue light cystoscopy imaging during transurethral resection of bladder tumors Scientific Reports volume 11, Article number: 11629 (2021)...

Non–Urothelial Variant Histology vs Urothelial Carcinoma Across All Stages and Treatment Modalities

Non–Urothelial Variant Histology vs Urothelial Carcinoma Across All Stages and Treatment Modalities

Journal Scan / Research · May 20, 2021 Non–Urothelial Variant Histology vs Urothelial Carcinoma Across All Stages and Treatment Modalities Clinical Genitourinary Cancer You've...

Trimodality Therapy With or Without Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer

Trimodality Therapy With or Without Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer

Journal Scan / Research · May 12, 2021 Trimodality Therapy With or Without Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer Clinical Genitourinary Cancer You've saved...

25 Facts About Bladder Cancer

25 Facts About Bladder Cancer

25 Facts About Bladder Cancer May 3, 2021 May is Bladder Cancer Awareness Month, a time to encourage understanding of this disease along with the raising of critical funds for...

Urological cancer patients receiving treatment during COVID-19: a single-centre perspective

Urological cancer patients receiving treatment during COVID-19: a single-centre perspective

british journal of cancer Abstract Background Active cancer, immunosuppressive treatments and immunotherapies have been reported to increase cancer patients’ risk of developing...

Mental Health Resource Use and Curative-Intent Treatment for Bladder Cancer

Mental Health Resource Use and Curative-Intent Treatment for Bladder Cancer

Journal Scan / Research · March 21, 2021 Mental Health Resource Use and Curative-Intent Treatment for Bladder Cancer Journal of the National Cancer Institute   You've saved your...

Feasibility of Patient-Reported Outcomes Among Racially Diverse Bladder and Prostate Cancer Patients

Feasibility of Patient-Reported Outcomes Among Racially Diverse Bladder and Prostate Cancer Patients

Journal Scan / Research · January 26, 2021 Feasibility of Patient-Reported Outcomes Among Racially Diverse Bladder and Prostate Cancer Patients Urologic Oncology: Seminars &...

Quality of Life After Bladder Cancer: A Cross-Sectional Survey of Patient-Reported Outcomes

Quality of Life After Bladder Cancer: A Cross-Sectional Survey of Patient-Reported Outcomes

Journal Scan / Research · March 17, 2021 Quality of Life After Bladder Cancer: A Cross-Sectional Survey of Patient-Reported Outcomes European Urology You've saved your first...